Phenox as partner of WLNC - World Live Neurovascular Conference in Los Angeles
This Year, phenox again acts as a sponsor for the 5th WLNC – World Live Neurovascular Conference, one of the most important conferences in the field of stroke therapy. The congress, which was held from 15 until 18 May in Los Angeles, CA, US, addressing neuroradiologists, neurosurgeons and neurologists all over the world. One of the main topics is the treatment of neurovascular strokes – a field in which phenox is one of the international leading companies. Every year the WLNC is hosted in different cities to highlight its international focus and collaboration within this field. The goal of this event is to discuss the newest findings of clinical studies and therapy options on the field of neurointerventional and cerebrovascular surgeries and by this improve the stroke treatment continuingly. As a gold-sponsor, phenox GmbH supports this development in a crutial way. And also in the last few years, the company already was a partner of the WLNC. What is groundbreaking about the WLNC is the approach of streaming live-cases from clinics all over the world. One of those clinics is La Sagrada Familia in Buenos, where phenox products are used to treat aneurysms since years. California, the location of the WLNC 2017, fittingly is a future-orientated location for the phenox corporation too. CEO Dr.-Ing. Hermann Monstadt states: „By opening a new sales location in Irvine, the US becomes, in addition to the German headquarter and a production site in Ireland, our third company location. The US is leading in the medical technology market worldwide, therefore this step is a big milestone within our business strategy.”
On the picture:
Prof. Naci Kocer (Cerrahpasa Medical School, Istanbul), Prof. Demetrius Lopes (Rush University Medical Center, Chicago), Dr.Ing. Hermann Monstadt (CEO phenox) and Prof. Saruhan Cekirge (Hacettepe University Hospitals, Ankara) at the tribute to the sponsors at the WLNC in Los Angeles.